By Simon Baron-Cohen — 2019
It remains controversial—but it doesn’t have to be. We need to embrace both the neurodiversity model and the medical model to fully understand autism.
Read on blogs.scientificamerican.com
CLEAR ALL
When a medication is being evaluated to modify the behavior of a person with autism, one must assess the risks versus the benefits.
1
This page is written by Temple Grandin and describes her journey and challenges as a woman affected by autism. Temple outlines the support she received, discusses sensory and auditory difficulties, tactile problems, her squeeze machine and many other topics.